Mice with disseminated candidiasis die of progressive sepsis

被引:180
作者
Spellberg, B
Ibrahim, AS
Edwards, JE
Filler, SG
机构
[1] Univ Calif Los Angeles, Los Angeles Cty Harbor Med Ctr, Los Angeles Biomed Res Inst, Div Infect Dis,St Johns Cardiovasc Res Ctr, Torrance, CA 90502 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA
关键词
D O I
10.1086/430952
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Candida species are among the most common etiologies of nosocomial bloodstream infections, causing a mortality of > 40%. The murine model of hematogenously disseminated candidiasis is the standard for investigating both the activity of antifungal agents and the pathogenesis of this disease. However, despite decades of use, little is known about the physiological characteristics of the host in this model, and the cause of death remains unclear. Methods. Using i-STAT technology, we measured blood chemistry and hemodynamic parameters to define host physiological characteristics during murine disseminated candidiasis. Results. Mice with hematogenously disseminated candidiasis died of progressive sepsis, as manifested by worsening hypotension, tachycardia, and hypothermia. The mice developed metabolic acidosis, as well as profound acidemia and hypoglycemia. They also developed renal insufficiency, which became severe only shortly before death. Kidney fungal burden was correlated with severity of renal failure and systemic acidosis. The presence of significant weight loss, hypotension, or hypothermia was predictive of imminent death. Conclusions. These findings indicate that the murine model of hematogenously disseminated candidiasis accurately recapitulates the progressive sepsis seen during severe clinical cases. The results underscore the validity of the model for study of the pathophysiological aspects of this disease, as well as for the evaluation of antifungal drug efficacy.
引用
收藏
页码:336 / 343
页数:8
相关论文
共 44 条
[1]   Candidemia in a tertiary care hospital:: Epidemiology and factors influencing mortality [J].
Alonso-Valle, H ;
Acha, O ;
García-Palomo, JD ;
Fariñas-Alvarez, C ;
Fernánez-Mazarrasa, C ;
Fariñas, MC .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (04) :254-257
[2]  
[Anonymous], 1998, The ICU Book
[3]   Mucosal and systemic candidiasis in IL-8Rh-/- BALB c mice [J].
Balish, E ;
Wagner, RD ;
Vazquez-Torres, A ;
Jones-Carson, J ;
Pierson, C ;
Warner, T .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (01) :144-150
[4]   Candidiasis in interferon-γ knockout (IFN-γ-/-) mice [J].
Balish, E ;
Wagner, RD ;
Vázquez-Torres, A ;
Pierson, C ;
Warner, T .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (02) :478-487
[5]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[6]   Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice [J].
Brieland, J ;
Essig, D ;
Jackson, C ;
Frank, D ;
Loebenberg, D ;
Menzel, F ;
Arnold, B ;
DiDomenico, B ;
Hare, R .
INFECTION AND IMMUNITY, 2001, 69 (08) :5046-5055
[7]   ROLE OF L3T4+ LYMPHOCYTES IN PROTECTIVE IMMUNITY TO SYSTEMIC CANDIDA-ALBICANS INFECTION IN MICE [J].
CENCI, E ;
ROMANI, L ;
VECCHIARELLI, A ;
PUCCETTI, P ;
BISTONI, F .
INFECTION AND IMMUNITY, 1989, 57 (11) :3581-3587
[8]   Efficacy of the partricin derivative SPA-S-753 against systemic murine candidosis [J].
Clemons, KV ;
Stevens, DA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (02) :183-186
[9]   Antifungal resistance in non-albicans Candida species [J].
Collin, B ;
Clancy, CJ ;
Nguyen, MH .
DRUG RESISTANCE UPDATES, 1999, 2 (01) :9-14
[10]   Antituberculosis activity of once-weekly rifapentine-containing regimens in mice - Long-term effectiveness with 6-and 8-month treatment regimens [J].
Daniel, N ;
Lounis, N ;
Ji, BH ;
O'Brien, RJ ;
Vernon, A ;
Geiter, LJ ;
Szpytma, M ;
Truffot-Pernot, C ;
Hejblum, G ;
Grosset, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (05) :1572-1577